Artemis Therapeutics, Inc. (ATMS) is a biopharmaceutical company developing novel treatments for serious and life-threatening infections. The company’s lead drug candidate, Artemisone, is a best-in-class artemisinin which has been studied in a phase 2 clinical trial for the treatment of malaria (p. falciparum) and is currently undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV), including transplant CMV and congenital CMV.
Company Details
- Employees
- 1
- Address
- 18 East 16th Street, New York,ny 10003,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- artemis-therapeutics.com
- HQ
- New York, NY
Artemis Therapeutics, Inc. Questions
Artemis Therapeutics, Inc.'s website is artemis-therapeutics.com
Artemis Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/artemis-therapeutics-inc
Artemis Therapeutics, Inc. has
1 employees.
View email and phone details for 1
employees at Artemis Therapeutics, Inc..
Artemis Therapeutics, Inc.'s industry is
Biotechnology Research
Artemis Therapeutics, Inc.'s top competitors are
Apmonia Therapeutics,
Celsius Therapeutics,
Tactical Therapeutics,inc,
Calder Biosciences Inc.,
Artms,
Darwin Health Communications,
Avatar Biotechnologies, Llc,
Archon Biosciences,
Avenue Therapeutics,
Aquavit Pharmaceuticals, Inc.
Artemis Therapeutics, Inc.'s categories are Biotechnology Research
